At BioSymetrics, the Phenograph is an exciting and important part of our approach to AI-powered, phenomics-driven drug discovery.
To unpack why, we interviewed our Co-Founder and Chief Scientific Officer Gabe Musso, PhD, below.
At BioSymetrics, the Phenograph is an exciting and important part of our approach to AI-powered, phenomics-driven drug discovery.
To unpack why, we interviewed our Co-Founder and Chief Scientific Officer Gabe Musso, PhD, below.